Medivir AB - ESG Rating & Company Profile powered by AI
If you work at Medivir AB and you would like to use your ESG rating, please get in touch. The page contains a Q&A section about Medivir AB. This ESG score for Medivir AB represents its reporting of the United Nations Sustainable Development Goals.
Medivir AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.7; made up of an environmental score of 8.0, social score of 8.0 and governance score of 4.0.
6.7
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
314 | Trulieve Cannabis Corp | 6.8 | High |
314 | Vicore Pharma Holding AB | 6.8 | High |
337 | Medivir AB | 6.7 | High |
337 | Calyxt Inc | 6.7 | High |
337 | CanSino Biologics Inc | 6.7 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Medivir AB have an accelerator or VC vehicle to help deliver innovation?
Does Medivir AB disclose current and historical energy intensity?
Does Medivir AB report the average age of the workforce?
Does Medivir AB reference operational or capital allocation in relation to climate change?
Does Medivir AB disclose its ethnicity pay gap?
Does Medivir AB disclose cybersecurity risks?
Does Medivir AB offer flexible work?
Does Medivir AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Medivir AB disclose the number of employees in R&D functions?
Does Medivir AB conduct supply chain audits?
Does Medivir AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Medivir AB conduct 360 degree staff reviews?
Does Medivir AB disclose the individual responsible for D&I?
Does Medivir AB disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Medivir AB disclose current and / or historical scope 2 emissions?
Does Medivir AB disclose water use targets?
Does Medivir AB have careers partnerships with academic institutions?
Did Medivir AB have a product recall in the last two years?
Does Medivir AB disclose incidents of discrimination?
Does Medivir AB allow for Work Councils/Collective Agreements to be formed?
Has Medivir AB issued a profit warning in the past 24 months?
Does Medivir AB disclose parental leave metrics?
Does Medivir AB disclose climate scenario or pathway analysis?
Does Medivir AB disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Medivir AB disclose the pay ratio of women to men?
Does Medivir AB support suppliers with sustainability related research and development?
Does Medivir AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Medivir AB reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Medivir AB involved in embryonic stem cell research?
Does Medivir AB disclose GHG and Air Emissions intensity?
Does Medivir AB disclose its waste policy?
Does Medivir AB report according to TCFD requirements?
Does Medivir AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Medivir AB disclose energy use targets?
Does Medivir AB disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Medivir AB have a policy relating to cyber security?
Have a different question?
Potential Risks for Medivir AB
These potential risks are based on the size, segment and geographies of the company.
Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology in Sweden and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It also develops Remetinostat for treating MF cutaneous T-cell lymphoma, as well as basal cell carcinoma. In addition, the company develops MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors. It has a research collaboration with the Drug Discovery and Development Platform at SciLifeLab for the discovery of antivirals for SARS CoV-2; and a licensing agreement with the Tango Therapeutics for a preclinical research program, as well as Ubiquigent Limited for the preclinical research program USP7. Medivir AB (publ) was incorporated in 1987 and is based in Huddinge, Sweden.